Hyperbilirubinemia

Hyperbilirubinemia is the indication for 1 drug in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Hyperbilirubinaemia · Bilirubinaemia · Bilirubinemia · Hyper Bilirubinemia
Classified under: Digestive System Diseases
Nutritional and Metabolic Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Phenobarbital

Resolves to

Vocabularies

MeSHM0010811SNOMED CT14783006MedDRA10004702UMLSC0020433

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

22Clinical trialsPhase, status and sponsor resolved per trial

2Contraindicated drugsDrugs whose labels contraindicate them in this condition

102Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Hyperbilirubinemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.